FIGURE 5.
Changes of tumor markers in the patient during chemotherapy. While tumor markers carcinoembryonic antigen and cancer antigen 19‐9 decreased for months in response to FOLFOX treatment, it increased consistently in response to FOLFIRI + Bev
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.